Clinical Trial Update: Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis [Phase 1]

View source ↗

Summary

Phase 1 trial of KHK7580 for secondary hyperparathyroidism in peritoneal dialysis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• KHK7580

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Secondary Hyperparathyroidism | Phase 1 | Status: COMPLETED